Evidence Files

Oscillococcinum: France's Bestselling Flu Remedy Is Made From Duck Liver Diluted Into Oblivion

The Cochrane review of Oscillococcinum has an unusual detail in its conflict-of-interest statement: all three authors are research-active in the field of homeopathy, one of them an adviser to the British Homeopathic Association. Their conclusion was still that the evidence is not compelling, and that on prevention there was no significant difference from placebo. When a sympathetic panel reaches that verdict, it carries weight.

Published: 20 June 2026

Verdict

TRICK (no evidence)

We searched PubMed and Cochrane Library for clinical evidence on Oscillococcinum. The Cochrane review covers six trials with 1,523 participants. On prevention of influenza-like illness it found no statistically significant difference from placebo (RR 0.48, 95% CI 0.17 to 1.34, p = 0.16). On treatment, two trials the reviewers judged 'low quality' showed a 7.7% absolute difference in symptom relief at 48 hours. Their stated conclusion — and we quote it rather than paraphrase, because the precise wording matters — is that there is insufficient good evidence to enable robust conclusions, that a clinically useful effect is not ruled out, but that given the low quality of the studies the evidence is not compelling.

Why France — and much of Europe — buys it every winter

Oscillococcinum is made by French company Boiron, the world's largest homeopathic manufacturer. It's been sold since 1925. In France it's a pharmacy staple — surveyed French pharmacists recommend it as frequently as conventional flu medicines.

The name sounds scientific. The packaging looks clinical. The product sits in the pharmacy next to evidence-based medicines. And at €10-15 for a box, it feels like a reasonable thing to try when you feel a flu coming on.

The regulatory story is revealing: in the EU, homeopathic products don't need to prove they work — they only need to prove they're safe and that there's a "homeopathic tradition" for their use. Duck liver extract has that tradition. That's why it can be sold in pharmacies without clinical evidence of effectiveness — and why the broader question of whether homeopathy does anything beyond placebo was settled in the research literature long before it was settled on pharmacy shelves.

What the science actually says

The Cochrane review is worth reading closely rather than quoting loosely, because its careful wording is more damaging than any summary.

On prevention: nothing. Two prophylaxis trials in 327 adults produced a risk ratio of 0.48 with a confidence interval from 0.17 to 1.34 and p = 0.16 — statistically indistinguishable from placebo. The wide interval means the data are simply too thin to say anything
On treatment: a small signal from trials the reviewers called low quality. Two treatment trials showed a 7.7% absolute difference in symptom relief at 48 hours. The reviewers' own assessment of those trials is the relevant context
The reviewers' conclusion, verbatim: there is insufficient good evidence to enable robust conclusions; a clinically useful effect is not ruled out; but given the low quality of the eligible studies, the evidence is not compelling
Who wrote that conclusion matters. The review's conflict-of-interest statement records that all three authors are research-active in homeopathy — one is Research Development Adviser to the British Homeopathic Association, another edits a homeopathy journal. This is disclosed properly and does not impugn the review; it does mean the finding came from people inclined to look favourably
The dilution problem remains unaddressed by any of this. 200C means one part in 10⁴⁰⁰. There are roughly 10⁸⁰ atoms in the observable universe. No molecule of the original duck liver preparation can remain, and no mechanism has been proposed for how a pharmacological effect would survive its absence
Safety is genuine — and beside the point. It is safe because it contains nothing pharmacologically active. The cost is money, and the risk is choosing it over care that works when flu turns serious

What the packaging implies vs. what the evidence shows

What the box implies

"Flu-like symptoms: fever, chills, body aches." Positioned next to paracetamol and ibuprofen. Clinical-looking language. Recommended by pharmacists. 90+ years of use.

What the evidence shows

No significant difference from placebo on prevention, and a treatment signal the reviewers themselves called low quality and not compelling. No active ingredient can remain at 200C. Ninety years of tradition is not evidence — and EU registration for homeopathic products required no efficacy trials, only safety and tradition.

Frequently asked questions

Does Oscillococcinum prevent flu?

No — this is the clearest part of the evidence. Cochrane's two prophylaxis trials covering 327 adults found no statistically significant difference from placebo, with a risk ratio of 0.48 and a confidence interval running from 0.17 to 1.34. That interval crosses 1, meaning the result is compatible with no effect at all. If you want to reduce your chance of flu, vaccination is the intervention with actual evidence behind it.

But some trials showed it worked, didn't they?

Two treatment trials showed a 7.7% absolute difference in symptom relief at 48 hours — and the Cochrane reviewers classified those same trials as low quality. Their overall conclusion is that a clinically useful effect cannot be ruled out, but that the evidence is not compelling. That is a considerably weaker statement than "it works", and it came from authors sympathetic to homeopathy.

What's actually in it?

Sucrose and lactose. The labelled active ingredient is an extract of duck liver and heart diluted to 200C — one part in 10⁴⁰⁰. For scale, the observable universe contains roughly 10⁸⁰ atoms. At that dilution not a single molecule of the starting material can remain in the tube, which is not a matter of opinion but of arithmetic.

If it's harmless, what's the objection?

The harm isn't pharmacological — it's what the purchase displaces. Money, first. Then the sense that flu is being treated when it isn't, which matters because influenza genuinely can become dangerous in older adults, pregnant women and people with chronic conditions. Antivirals exist and work best within the first 48 hours; a box of sugar taken instead is 48 hours spent.

How is it sold in pharmacies without efficacy evidence?

Because EU rules for registering homeopathic products do not require proof that they work. A manufacturer must demonstrate safety and an established homeopathic use, not clinical efficacy. That is why a product can sit on a pharmacy shelf beside paracetamol while having a fundamentally different evidentiary status — a distinction the packaging does nothing to communicate.

Our Conclusion

Oscillococcinum is probably the purest example of what evidence-based medicine calls a placebo with a brand name — and the most telling evidence for that comes from the friendliest possible source. The Cochrane review was written by three authors all research-active in homeopathy, and their conclusion was that the evidence is not compelling, with no significant difference from placebo on prevention. At 200C dilution no molecule of the original preparation can remain, so there is nothing for a mechanism to act through. It is safe, because sugar is safe. It is made by a reputable company and sold in legitimate pharmacies, and neither fact bears on whether it works. If you have flu symptoms, paracetamol or ibuprofen will bring down fever and ease the aches. If you're in a group where flu turns serious — older, pregnant, chronically ill — the thing that matters is seeing a doctor within the first 48 hours, because that is the window in which real antivirals work. That window is the actual cost of a box of sugar.

Sources

Every claim in this article rests on a primary publication. Links go to the publisher's site or to PubMed, the US National Library of Medicine database.

This article is for informational purposes only and does not constitute medical advice. Trick or Treatment analyses the presence of clinical studies in open scientific databases — PubMed and Cochrane Library. The absence of studies in these databases does not automatically mean a drug is ineffective, but it does mean its effectiveness has not been confirmed by evidence-based medicine standards. Any treatment decisions should be made together with your doctor.